Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis ; volume:14 ; number:1 ; day:7 ; month:3 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (7.3.2024), 1-12, 12.2024
- Creator
-
She, Xianhua
Yin, Donghong
Guo, Qian
Tang, Yang
Wang, Shuyun
Wang, Xuyan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-56335-4
- URN
-
urn:nbn:de:101:1-2405102113516.406344172879
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- She, Xianhua
- Yin, Donghong
- Guo, Qian
- Tang, Yang
- Wang, Shuyun
- Wang, Xuyan
- SpringerLink (Online service)
Other Objects (12)
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Hybrid Screen Printable Electrolyte for Large‐Scale Flexible Electrochromic Display Production
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Renal and electrolyte complications in eating disorders: a comprehensive review
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
Impact of dietary nitrogen reduction on electrolyte homeostasis in growing goats with a focus on renal electrolyte handling
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Hybrid Screen Printable Electrolyte for Large‐Scale Flexible Electrochromic Display Production
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Renal and electrolyte complications in eating disorders: a comprehensive review
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
Impact of dietary nitrogen reduction on electrolyte homeostasis in growing goats with a focus on renal electrolyte handling
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Hybrid Screen Printable Electrolyte for Large‐Scale Flexible Electrochromic Display Production
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Renal and electrolyte complications in eating disorders: a comprehensive review
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance